University of California, San Diego
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of California, San Diego sits in the top decile of US sponsors by registered trial count (#43 of 15,742 sponsors by registered trial count).
University of California, San Diego: 775 sponsored US clinical trials, 143 recruiting.
University of California, San Diego sponsors 775 registered US clinical trials on ClinicalTrials.gov, 143 of them currently recruiting, and 499 completed. 104 of these trials are in Phase 3-4 (later-stage) and 170 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Anorexia Nervosa, with 10 trials.
Top-decile sponsor footprint
University of California, San Diego ranks in the top decile of sponsors by registered trial count (#43 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
499 of 553 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (90.2%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
775 total, page 9 of 16
Ovarian Response to Recombinant Follicle Stimulating Hormone in Women With PCOS
NCT03252223
Cerebral MRI During Sleep
NCT03304652
Effects of Health Literacy and HCV Knowledge on HCV Treatment Willingness in HIV-coinfected Patients
NCT03413696
Effect of Vestibular Stimulation on Fat Consumption and Energy Expenditure as Assessed Using Indirect Calorimetry
NCT03138382
Blinatumomab & Pembrolizumab for Adults With Relapsed/Refractory B-cell ALL With High Marrow Lymphoblasts
NCT03160079
Linkage of Transgender Individuals to PrEP
NCT03191474
The Impact of Time Restricted Feeding (TRF) in Improving the Health of Patients With Metabolic Syndrome
NCT03182985
Effects of Melatonin on Sleep, Ventilatory Control and Cognition at Altitude.
NCT03368352
Randomized Controlled Trial of iTAB Plus Motivational Interviewing for PrEP Adherence in Transgender Individuals
NCT03086200
Effect of Heat Stress on Global LV Function in Anesthetized Humans
NCT04553900
Effects of Avocado Intake on the Nutritional Status of Families
NCT02903433
FRESH-DOSE: Families Responsibility Education Support Health-Dual Options for Sustained Effectiveness
NCT03096132
Reinforced Enhanced - Families Responsibility Education Support and Health
NCT02976636
Trial to Reduce Sitting Time in Postmenopausal Latina Women at Increased Risk for Heart Disease
NCT02905929
Pembrolizumab Combined With Cetuximab for Treatment of Recurrent/Metastatic Head & Neck Squamous Cell Carcinoma
NCT03082534
Studying the Effectiveness of Non-Invasive Glucose Sensors in Patients With Diabetes: The SENSOR Study
NCT02800044
The Role of Opioidergic Systems in Breathing Based Analgesia
NCT03419858
Prostate Artery Embolization for the Treatment of Symptomatic Benign Prostatic Hyperplasia
NCT03055624
The Impact and Detection of Driving Impairments Associated With Acute Cannabis Smoking
NCT02849587
Percutaneous Peripheral Nerve Stimulation (Neuromodulation) for Postoperative Analgesia
NCT02898103
KIDCARE (Kawasaki Disease Comparative Effectiveness Trial)
NCT03065244
Phase II Trial of Tesamorelin for Cognition in Aging HIV-Infected Persons
NCT02572323
The Pathogenesis of OSA in People Living With HIV
NCT03064204
Guided Self-Help Obesity Treatment in the Doctor's Office - GOT Doc
NCT02976454
Sensation and Skin Pressures Under Blood-Draw Tourniquets
NCT03187041
Trial of Dronabinol and Vaporized Cannabis in Chronic Low Back Pain
NCT02460692
Cue-Reward Learning and Weight Gain in Youth
NCT03254576
Extension Study of UC-961 (Cirmtuzumab) for Patients With Chronic Lymphocytic Leukemia Treated Previously With UC-961
NCT02860676
Erythropoietin to Prevent Unnecessary Transfusions In Patients With Cyanotic CHD - A Prospective Control Trial
NCT02564796
Mobile Biosensor for Measuring Vital Signs in Healthcare and Home Settings
NCT04233827
The Role of Osteopathic Manipulation in the the Management of Post-traumatic Migraine
NCT03588364
Checkpoint Blockade Immunotherapy Combined With Stereotactic Body Radiation in Advanced Metastatic Disease
NCT02843165
Perturbing of HIV Reservoir With Immune Stimulation
NCT02707692
Primary Care-Based Physical Activity for Diabetic Latinas
NCT02741050
A Controlled Trial of Losartan in Posttraumatic Stress Disorder
NCT02709018
Senior Change Makers Study: Improving Physical Activity Environments
NCT02944838
High-risk Obstetrical Patient Intervention Utilizing the Contraceptive CHOICE Project Script
NCT03049592
Evaluation of the Inhibitory Effects of Topical Ivermectin on Markers of Rosacea Specific Inflammation.
NCT02806414
Clinical Trial of Anti-oxidant Astaxanthin in Insulin-resistant Subjects
NCT03310359
Comparing Rate Response With CLS Versus Accelerometer ICD Settings in Heart Failure Patients With BIOTRONIK CRT-Ds
NCT02693262
Neural Bases of Multiple Forms of Self-regulatory Control in Bulimia Nervosa
NCT02997475
The Effects of Type 1 Diabetes Mellitus and Increased Weight on Gut Microbiome and Urine Metabolome Profiles in Children
NCT02938806
A Novel Healthcare Information Technology Tool to Improve Care in Patients With Atrial Fibrillation
NCT02623517
Evaluating Household Visits and Small Groups to Increase Contraception Use Among Married Adolescent Girls in Rural Niger
NCT03226730
Evaluation of the Efficacy of an Autologous Microbiome Transplant in Adult Atopic Dermatitis Patients
NCT03158012
Sedentary Behavior Interrupted - A Pilot Study of Acute Interventions on Prolonged Sitting
NCT02743286
VDOT for Monitoring Adherence to LTBI Treatment
NCT02641106
Nuts and Olestra for Persistent Organic Pollutant Reduction (NO-POPs) Trial
NCT02675101
The Impact of Venlafaxine on Apnea Hypopnea Index in Obstructive Sleep Apnea
NCT02714400
Culturally and Linguistically Adapted Physical Activity Intervention for Latinas
NCT02630953
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 80 |
| Phase 2 | 90 |
| Phase 3 | 22 |
| Phase 4 | 82 |
Therapeutic Areas
What is open in the University of California, San Diego pipeline
143 recruiting of 775 indexed (18% open); 499 completed (64%).
Phase mix: 104 late (III/IV) vs 170 early (I/II) (early-phase heavy).
Top condition: Anorexia Nervosa (10 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of California, San Diego: open-pipeline peers nationwide
Peers matched on 775 registered trials and 18% open enrollment, not the therapeutic-area sidebar.
University of California, San Diego sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 775 trials (± recruiting share)
- Dana-Farber Cancer Institute · 781 trials · 14% recruiting
- Medical University of South Carolina · 755 trials · 19% recruiting
- University of Chicago · 796 trials · 20% recruiting
- University of Utah · 818 trials · 17% recruiting
Sponsors near 18% open enrollment (± trial volume)
- Neurocrine Biosciences · 18% recruiting · 65 trials
- Thomas Jefferson University · 18% recruiting · 292 trials
- Abramson Cancer Center at Penn Medicine · 18% recruiting · 402 trials
- University of Maryland, Baltimore · 18% recruiting · 560 trials
Related
What to do with this University of California, San Diego page
775 registered trials is a research-attention snapshot, not an endorsement of University of California, San Diego or any single study.
- 143 of University of California, San Diego's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Anorexia Nervosa is the condition University of California, San Diego studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Anorexia Nervosa trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of California, San Diego pipeline card: 775 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.